Time for your weekly edition of the Defector Funbag. Got something on your mind? Email the Funbag. And buy Drew’s book, The Night The Lights Went Out, while you’re at it. Today, we’re talking about ...

SURVEY SAYS: Just 18% of the health-care plans sponsored by employers with 200 workers or more cover such drugs, according to ...

Novo Nordisk NVO announced positive top-line data from a late-stage cardiovascular outcomes study that evaluated its oral ...

Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

New guidelines from the AHA and ASA recommend GLP-1 drugs like Ozempic and Wegovy for stroke prevention in patients with ...

Starting next year, insurance companies, including Highmark, will introduce stricter requirements for covering GLP-1 weight ...

You’ve probably heard about the dramatic weight loss that can happen when you take Ozempic or Wegovy. These medications mimic ...

For the first time in a decade, the American Heart Association and American Stroke Association issued new recommendations for ...

A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...

Novo Nordisk on Monday reported the oral version of its drug semaglutide reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes by 14% in a large Phase III trial.